Carnitine: a false dawn in the treatment of muscle weakness in end-stage renal failure patients?
Davenport
Andrew
A
Department of Nephrology and Transplantation, Royal Free Hospital, London, UK.
D002331:Carnitine / Q000627:therapeutic use*; D017079:Exercise Tolerance / Q000187:drug effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism; D018908:Muscle Weakness / Q000188:drug therapy* / Q000209:etiology; D018482:Muscle, Skeletal / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism*; D006435:Renal Dialysis; D017211:Treatment Failure
D002331:Carnitine